Procalcitonin (CAS 56645-65-9) Market Report – Research, Industry Analysis Reports and Market Demands

Global Procalcitonin (CAS 56645-65-9) Market Growth 2019-2024

Request for Sample of this report

Buy now

Table of Content

2019-2024 Global Procalcitonin (CAS 56645-65-9) Consumption Market Report

1 Scope of the Report

2 Executive Summary

2.1 World Market Overview
- 2.1.1 Global Procalcitonin (CAS 56645-65-9) Consumption 2014-2024
- 2.1.2 Procalcitonin (CAS 56645-65-9) Consumption CAGR by Region
2.2 Procalcitonin (CAS 56645-65-9) Segment by Type
- 2.2.1 Procalcitonin Antigen
- 2.2.2 Procalcitonin Antibody
2.3 Procalcitonin (CAS 56645-65-9) Consumption by Type
- 2.3.1 Global Procalcitonin (CAS 56645-65-9) Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Procalcitonin (CAS 56645-65-9) Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Procalcitonin (CAS 56645-65-9) Sale Price by Type (2014-2019)
2.4 Procalcitonin (CAS 56645-65-9) Segment by Application
- 2.4.1 Medical Industry
- 2.4.2 Scientific Research
2.5 Procalcitonin (CAS 56645-65-9) Consumption by Application
- 2.5.1 Global Procalcitonin (CAS 56645-65-9) Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Procalcitonin (CAS 56645-65-9) Value and Market Share by Application (2014-2019)
- 2.5.3 Global Procalcitonin (CAS 56645-65-9) Sale Price by Application (2014-2019)

3 Global Procalcitonin (CAS 56645-65-9) by Players

3.1 Global Procalcitonin (CAS 56645-65-9) Sales Market Share by Players
- 3.1.1 Global Procalcitonin (CAS 56645-65-9) Sales by Players (2017-2019)
- 3.1.2 Global Procalcitonin (CAS 56645-65-9) Sales Market Share by Players (2017-2019)
3.2 Global Procalcitonin (CAS 56645-65-9) Revenue Market Share by Players
- 3.2.1 Global Procalcitonin (CAS 56645-65-9) Revenue by Players (2017-2019)
- 3.2.2 Global Procalcitonin (CAS 56645-65-9) Revenue Market Share by Players (2017-2019)
3.3 Global Procalcitonin (CAS 56645-65-9) Sale Price by Players
3.4 Global Procalcitonin (CAS 56645-65-9) Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Procalcitonin (CAS 56645-65-9) Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Procalcitonin (CAS 56645-65-9) Products Offered
3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Procalcitonin (CAS 56645-65-9) by Regions

4.1 Procalcitonin (CAS 56645-65-9) by Regions
- 4.1.1 Global Procalcitonin (CAS 56645-65-9) Consumption by Regions
- 4.1.2 Global Procalcitonin (CAS 56645-65-9) Value by Regions
4.2 Americas Procalcitonin (CAS 56645-65-9) Consumption Growth
4.3 APAC Procalcitonin (CAS 56645-65-9) Consumption Growth
4.4 Europe Procalcitonin (CAS 56645-65-9) Consumption Growth
4.5 Middle East & Africa Procalcitonin (CAS 56645-65-9) Consumption Growth

5 Americas

5.1 Americas Procalcitonin (CAS 56645-65-9) Consumption by Countries
- 5.1.1 Americas Procalcitonin (CAS 56645-65-9) Consumption by Countries (2014-2019)
- 5.1.2 Americas Procalcitonin (CAS 56645-65-9) Value by Countries (2014-2019)
5.2 Americas Procalcitonin (CAS 56645-65-9) Consumption by Type
5.3 Americas Procalcitonin (CAS 56645-65-9) Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Procalcitonin (CAS 56645-65-9) Consumption by Countries
- 6.1.1 APAC Procalcitonin (CAS 56645-65-9) Consumption by Countries (2014-2019)
- 6.1.2 APAC Procalcitonin (CAS 56645-65-9) Value by Countries (2014-2019)
6.2 APAC Procalcitonin (CAS 56645-65-9) Consumption by Type
6.3 APAC Procalcitonin (CAS 56645-65-9) Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe

7.1 Europe Procalcitonin (CAS 56645-65-9) by Countries
- 7.1.1 Europe Procalcitonin (CAS 56645-65-9) Consumption by Countries (2014-2019)
- 7.1.2 Europe Procalcitonin (CAS 56645-65-9) Value by Countries (2014-2019)
7.2 Europe Procalcitonin (CAS 56645-65-9) Consumption by Type
7.3 Europe Procalcitonin (CAS 56645-65-9) Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

8.1 Middle East & Africa Procalcitonin (CAS 56645-65-9) by Countries
- 8.1.1 Middle East & Africa Procalcitonin (CAS 56645-65-9) Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Procalcitonin (CAS 56645-65-9) Value by Countries (2014-2019)
8.2 Middle East & Africa Procalcitonin (CAS 56645-65-9) Consumption by Type
8.3 Middle East & Africa Procalcitonin (CAS 56645-65-9) Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
10.2 Procalcitonin (CAS 56645-65-9) Distributors
10.3 Procalcitonin (CAS 56645-65-9) Customer

11 Global Procalcitonin (CAS 56645-65-9) Market Forecast

11.1 Global Procalcitonin (CAS 56645-65-9) Consumption Forecast (2019-2024)
11.2 Global Procalcitonin (CAS 56645-65-9) Forecast by Regions
- 11.2.1 Global Procalcitonin (CAS 56645-65-9) Forecast by Regions (2019-2024)
- 11.2.2 Global Procalcitonin (CAS 56645-65-9) Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
11.7 Global Procalcitonin (CAS 56645-65-9) Forecast by Type
11.8 Global Procalcitonin (CAS 56645-65-9) Forecast by Application

12 Key Players Analysis

13 Research Findings and Conclusion

Description

Procalcitonin (PCT) is a 116 amino acid residue protein with a molecular weight of approximately 13kDa. Procalcitonin is a peptide hormone mainly produced by the C cells of the thyroid and certain endocrine cells of the lung. Under normal expression conditions, procalcitonin is immediately cleaved into three specific fragments, an N terminal residue, calcitonin and katacalcin. It can be expressed in E. coli
Sepsis is a life-threatening organ dysfunction caused by an excessive host immune response to a serious infection. According to the Centers for Disease Control and Prevention (CDC), 1.6 million Americans suffered from sepsis in 2011, of which about 260,000 did not survive. PCT can play a critical role in addressing this clinical challenge and has become a key component of successful sepsis protocols across the U.S. and Europe. PCT levels increase precipitously in patients with severe bacterial infection. PCT is therefore an extremely important biomarker enabling specific differentiation between a severe bacterial infection and other causes of inflammatory reactions.
Expressed in E.coli, PCT can be used as a reagent to prepare calibrators for procalcitonin or calcitonin immunoassays.

The global procalcitonin market had reached 126.4 g in 2016 and is expected to increase reach 212.6 g by 2023. In terms of revenue, the global procalcitonin chloride market was valued 61.85 Million USD in 2016, and is estimated to be worth 92.27 Million USD by 2023. Overall, the procalcitonin products performance is positive with the global economic recovery.

The manufacture region is concentrated in USA, Europe, China and Japan, of which Europe is the largest region with the share 36.92% in 2016. The production shares of Europe, China and Japan were 23.07%, 19.12% and 6.43%.

The consumption share of North America, Europe, Asia Pacific were 26.73%, 28.27%, 35.77% in 2016. Asia Pacific is the main export region.

There are companies adding new capacities and aims at the cost and quality leadership which shall improve profitability. As the same time, companies are focusing on technological innovation, equipment upgrades, and process improvements, to reduce costs and improve quality. The competition in Procalcitonin market will become more intense.

According to this study, over the next five years the Procalcitonin (CAS 56645-65-9) market will register a 6.4% CAGR in terms of revenue, the global market size will reach US$ 90 million by 2024, from US$ 62 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Procalcitonin (CAS 56645-65-9) business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Procalcitonin (CAS 56645-65-9) market by product type, application, key manufacturers and key regions and countries.

This study considers the Procalcitonin (CAS 56645-65-9) value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Procalcitonin Antigen
Procalcitonin Antibody
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Medical Industry
Scientific Research

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Thermo Fisher
Roche Diagnostics
bioMerieux
HyTest
BBI Solutions
ProSpec
Wondfo
Ningbo Medicalsystem Biotechnology
Wuhan Easy Diagnosis Biomedicine
Snibe
Vazyme Biotech
Getein Biotech
Hotgen Biotech
Lumigenex
Nanjing Norman Biological Technology
Shanghai Medicine'nest Pharmaceutical
Kitgen
Beijing KeyGen
Beijing Apis

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Procalcitonin (CAS 56645-65-9) consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Procalcitonin (CAS 56645-65-9) market by identifying its various subsegments.
Focuses on the key global Procalcitonin (CAS 56645-65-9) manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Procalcitonin (CAS 56645-65-9) with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Procalcitonin (CAS 56645-65-9) submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.